attachment
A bridge between patients' needs for cannabis and the quality standards of modern medicine. Thank you for putting your trust in Bedrocan Canada Inc. Click Here to view the newsletter in your browser. twitter twitter YOUR ONLINE STORE IS NOW OPEN CUSTOMERS CAN NOW PLACE ORDERS SECURELY VIA THE WEB A special thank you goes out to those patients who assisted in testing the online store and providing invaluable feedback. Patients will benefit from: • improved access to Bedrocan’s inventory and selection of cannabis varieties • convenience in selecting full-flower bud or granulate options • flexible payment methods • view order history to help plan & monitor purchases Login credentials have been emailed to registered customers. If you have not yet received your login information please contact customer care at 1-855-420-7887. -------------------------------------------------------------------------------- LIMITED TIME PROMOTION ON BEDICA: $6.50 per gram For a limited time only all Bedica orders placed through the website will qualify for a 13% discount! In celebration of the launch of the online store, Bedrocan is offering customers a promotional price for all orders of Bedica that are placed through the online store. The promotional pricing will only be available for orders place between now and April 30th 2015, and only orders placed through the online store will qualify for the promotional discount. Bedica is a 14% THC Indica variety. -------------------------------------------------------------------------------- HEALTH CANADA LICENSES BEDROCAN'S NEW CANADIAN FACILITY State-of-the-art facility enables Bedrocan to begin production of medical cannabis in Canada. The shift to domestic production is a significant step in boosting Bedrocan's capacity to serve the needs of Canadian patients. It will also enable a consistent supply of the same products that Canadian patients have come to rely upon. The process of importing live genetics (cannabis plant clones) is underway from the Netherlands to Canada. These plants will become the next generation of Bedrocan's medicinal cannabis grown in Canada. Because the plants are genetic clones, they will retain the identical in composition of THC, CBD, and terpene profiles of the cannabis that has previously been imported. -------------------------------------------------------------------------------- PATIENT RENEWALS & EXPIRATION DATES Things to know before placing your order as renewal time approaches Under the MMPR, patients are authorized to possess a certain amount of medical cannabis for a specific period of time. As the expiration date approaches, patients must renew their registration. Remember the following: Don’t Let Your Bedrocan Registration Expire! In order to remain registered with Bedrocan, you will need to renew your registration every time that your prescription expires. Prescriptions are valid for up to 1 year, but many doctors prescribe for less than 12 months. So you will need to renew at least once per year. Bedrocan customer care team will attempt to contact you 6-8 weeks before your expiry date, but it is your responsibility to ensure that the renewal process is started with enough time to keep your registration status active. The customer care team is available to assist answer your questions about your renewal and help you make sure that things go smoothly. They can be reached at 1-855-420-7887. How to Renew Your Registration: Know the date that your registration expires You may not possess medicinal cannabis after that date. The expiration date is printed on your Bedrocan ID card as well as on your Bedrocan Registration Document. It is also written on your Medical Document. Complete the Renewal Application This must be completed by you, the client. You can submit it through our website www.bedrocan.ca in the ‘For Patients’ section under ‘Submit Your Renewal Documents’. Click on the “Fill and file your renewal online” link and complete and sign the form. Make an appointment with your doctor to obtain a renewed Medical Document (prescription). You can download and print a blank copy of the form from our website. If you do not have a printer, we can mail you a copy of the Medical Document to take to the doctor. Send the Renewal Application to Bedrocan The Renewal Form can be submitted: 1. Through our website: https://bedrocan.ca/renewals/ 2. By email attachment to info@bedrocan.ca with the subject: “Renewal Documents” 3. By fax to 416-943-5804; or 4. By mail: 250A Eglinton Ave East PO BOX 89589 Toronto,ON, M4P 3E1 The Medical Document must be submitted in its original form – we encourage you to keep a copy and send the original by Canada Post Express (so you can track it’s progress to delivery). Your period of use begins on the date that the doctor signs the Medical Document, so we encourage you to send the documents as quickly as possible once they are prepared. We will make every effort to renew your registration promptly once we receive your documents, but it is essential that all the documents are completed correctly. Please feel free to contact us if you have any questions. As Your Registration is Approaching Its Expiry: It is important to understand that if your registration is set to expire in fewer than 30 days, there will be a strict limit on the amount of medication that you will be able to order, because you may not possess any medicinal cannabis past your expiry date. So in the last month before your prescription expires, we will only be able to ship your daily maximum for the number of days left in your prescription. A typical example: For example, Greg is authorized to possess 50 grams of cannabis per month. However he is 15 days away from expiration. He is only permitted to possess 15 days worth of cannabis out of 30 days in the month. So he can only obtain 50% of his monthly limit (15 divided by 30). When Greg calls to place an order, we can only ship him 25 grams of cannabis (half of his monthly limit). If Greg were to call on the last day of his authorization, we could not ship any cannabis until he has submitted his updated renewal documents. If you are within 30 days of expiration, you must call the customer care team to place your order, orders through the website will not be accepted. -------------------------------------------------------------------------------- BEDROCAN LAUNCHES PATIENT ADVISORY BOARD (PAB) The PAB will advise Bedrocan on Patient Education Needs, Customer Care, Interactions with Health Professionals, and Anti-Stigma Efforts. Leading Medical Cannabis Advocate Hilary Black Joins Bedrocan as Director of Patient and Community Services. Bedrocan is pleased to announce the establishment of a Patient Advisory Board to provide insights on the experience of medicinal cannabis patients, how patients use cannabis and other medicines, and how Bedrocan can best meet the needs of current and future patients. The Advisory Board currently includes nine patients with a wide range of chronic health conditions, including post-cancer pain, neuropathic pain, multiple sclerosis, fibromyalgia, persistent headache, and colitis, as well as the mother of a child with Dravet Syndrome, a rare and catastrophic form of pediatric epilepsy. The Patient Advisory Board will counsel Bedrocan on patient education needs, continuous improvement in the customer care process, interactions with healthcare professionals regarding medicinal cannabis, and addressing the stigma sometimes associated with the use of cannabis to manage the symptoms of chronic health conditions. In addition, the Company announced the appointment of Hilary Black, a leading Canadian medicinal cannabis advocate, as Director of Patient and Community Services. Ms. Black is the founder of the British Columbia Compassion Club Society (BCCCS), the first medical cannabis dispensary in Canada, has consulted for the Canadian Consortium for the Investigation of Cannabis (CCIC), and was a co-author of The Patient Handbook on Medical Cannabis with Dr. Danial Schecter and Dr. Mark Ware. In 2013, she received the Queen’s Diamond Jubilee Medal, recognizing an outstanding contribution to Canada for founding the BCCCS, and for 17 years of patient advocacy. Among Ms. Black’s responsibilities will be managing Bedrocan’s patient education and outreach initiatives, as well as the Patient Advisory Board. “Bedrocan’s professional and responsible approach, to include the patient’s experience as well as the doctor’s perspective, is an important reason why I’m excited to be part of the first medicinal cannabis Patient Advisory Board in Canada,” said Grant Wallace, an Advisory Board member and businessperson living in Oakville, Ontario. “I’ve been using prescription medicines for 30 years to treat migraines, chronic fatigue and fibromyalgia, with only partial success. Bedrocan’s medicinal cannabis has been very effective in helping me manage my symptoms, and I want to support the company in helping more patients to get access to standardized, pharmaceutical-grade medicinal cannabis.” “The body of clinical evidence on the safe and effective therapeutic use of cannabis is growing rapidly, but unfortunately, because of the street use of marijuana, there is still a certain stigma associated with the legitimate use of medicinal cannabis,” said Marc Wayne, President and CEO of Bedrocan. “Patients’ voices are an important and powerful element of the public discussion of this regulated medicine. We have to listen to and learn from the experience of patients with chronic illnesses who can describe the benefits they have received from appropriate use of cannabis, under the care and supervision of a health care provider.” “The addition of Hilary Black to the Bedrocan team significantly enhances our ability to work collaboratively with patients, patient groups and health professional organizations,” added Mr. Wayne. “Her strong reputation in this field, along with her wealth of experience in patient advocacy, make her the ideal person to lead our patient and community services initiatives, as well as to coordinate the work of our Patient Advisory Board.” -------------------------------------------------------------------------------- WE WANT TO HEAR FROM YOU Do you have an idea for a topic or article that you want to see in the Newsletter? We would love to hear your suggestions and ideas for the Newsletter. Please email any suggestions to: info@bedrocan.ca with the subject: "Newsletter Ideas". -------------------------------------------------------------------------------- How to Reach Bedrocan We love to hear your feedback. You can always send us an email, call us, or visit our Twitter and Facebook pages to ask questions or send us your comments. We post our newsletters on our website here: www.bedrocan.ca/newsletter . Thank you for taking the time to read our newsletter. Should you have any questions about the content of this message, the MMPR program, the medicinal cannabis industry or Bedrocan Canada, please get in touch with us; we’d like to hear from you! Bedrocan Canada customer service professionals await your registration, orders and questions: In the GTA: 416-943-5800 Outside the GTA (Canada only) Toll-Free: 1-855-420-7887 Email us at: info@bedrocan.ca Copyright © 2015 Bedrocan Canada Inc., All rights reserved. You are receiving this email because you are an existing Bedrocan client. Our mailing address is: Bedrocan Canada Inc. PO Box 89589 250A Eglinton Ave, E Toronto, ON M4P 3E1 Canada Add us to your address book forward to a friend unsubscribe from this list update subscription preferences Email Marketing Powered by MailChimp No virus found in this message. Checked by AVG - www.avg.com Version: 2015.0.5751 / Virus Database: 4299/9220 - Release Date: 03/03/15